Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Drug Information » FDA Approved Drugs » 1999
Medical Areas: Hematology

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Lovenox (enoxaparin sodium) Injection

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Rhone Poulenc Rorer
Approval Status: Approved January 1999
Treatment Area: Hematology

General Information

Lovenox has been approved for the following indications: (1) the inpatient treatment of acute deep vein thrombosis with and without pulmonary embolism, when administered in conjunction with warfarin sodium, and (2) the outpatients treatment of acute deep vein thrombosis without pulmonary embolism when administered in conjunction with warfarin sodium.